.BETA.-D-GLUCOPYRANOSIDURONIC ACID, (4S)-4-(CYCLOPROPYLETHYNYL)-5,6-DIFLUORO-1,2,3,4-TETRAHYDRO-2-OXO-4-(TRIFLUOROMETHYL)-8-QUINAZOLINYL
UNII T2TC948JCG
Substance Identification & Data
This profile provides standardized clinical and technical data for .beta.-d-glucopyranosiduronic Acid, (4s)-4-(cyclopropylethynyl)-5,6-difluoro-1,2,3,4-tetrahydro-2-oxo-4-(trifluoromethyl)-8-quinazolinyl, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T2TC948JCG.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 540738-23-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H17F5N2O8 GRVNNXGAKCKICE-UFPCOPRLSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for .beta.-d-glucopyranosiduronic Acid, (4s)-4-(cyclopropylethynyl)-5,6-difluoro-1,2,3,4-tetrahydro-2-oxo-4-(trifluoromethyl)-8-quinazolinyl. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.